Hera-MI logo

Hera-MI

Shaping the future of radiology by making AI & Radiologists working together to improve breast cancer early detection

22 employees · est. 2017 · Saint-herblain, France

VS
Optellum logo

Optellum

Early lung cancer diagnosis with AI

49 employees · est. 2016 · Oxford, United Kingdom

Optellum is the older company (2017 vs 2016).

Side-by-Side Comparison

Hera-MI Optellum
Founded
2017 2016 older
Headquarters
Saint-herblain, France Oxford, United Kingdom
Employees
22 49
Industry
AI, Biotechnology, Health Care Health Care, Medical Devices, Machine Learning
Funding Stage
Non Equity Assistance Series A
Total Funding
Not tracked yet $15.05M
Funding Rounds
1 3
Services
Development of AI-powered software solutions for breast cancer diagnosis and mammography analysis AI-powered lung cancer diagnosis and precision care platform
Target Customers
Radiologists, senologists, healthcare institutions healthcare providers, healthcare professionals, hospitals, health systems
Taxonomy
Breast Cancer, Mammography, Tomosynthesis, MRI, 3D Ultrasound, Elastography, Image Processing, Medical Imaging, Clinical Decision Support System, Senology, CAD, Digital Medical Imaging, Early-stage Diagnosis, Healthcare Innovation Medical Diagnostics, Digital Health, Cancer, Deep Learning, Big Data, Patient Stratification, Medical Imaging, Lung Cancer, Early Diagnosis, Treatment, Oncology
Website
hera-mi.com optellum.com
Hera-MI logo

About Hera-MI

Hera-MI is a startup based in France founded in 2017 with a mission to shape the future of radiology by utilizing AI and radiologists to enhance early detection of breast cancer. The company is focused on leveraging AI to increase the recovery rate and optimize healthcare treatment for women. Hera-M...

Optellum logo

About Optellum

Optellum, a UK-based startup, is revolutionizing early diagnosis and treatment of lung cancer using Artificial Intelligence and Machine Learning. The company's mission is to ensure that every lung cancer patient receives the most effective treatment at the earliest possible stage. Their pioneering C...

We will tell you when either one moves

BounceWatch watches Hera-MI and Optellum for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Hera-MI and Optellum — by email.

Frequently Asked Questions

Hera-MI — Shaping the future of radiology by making AI & Radiologists working together to improve breast cancer early detection. Optellum — Early lung cancer diagnosis with AI. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Hera-MI has raised undisclosed funding while Optellum has raised $15.05M.
Hera-MI and Optellum operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Hera-MI with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Hera-MI on 11 Jun 2025, and Optellum on 25 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy